Courses Event Cardiology 2006: Issues and Controversies?Answering YOUR questions?

Continuing Medical Education

Cardiology 2006: Issues and Controversies

Presentation Date: March 11, 2006
Credits: N/A

Selected Presentations

CV Disease in Diabetes and the Metabolic Syndrome Robert A. Vogel, MD
Update in Coronary Interventions:2006 Jeffrey J. Popma, MD
CT Angiography Matthew J. Budoff, MD
Advances in Antithrombotic Therapy for ACS Marc Cohen, MD
Issues and Controversies in PVD Zvonimir Krajcer, MD
Keynote: Biomarkers: Past, Present, and Future Paul M. Ridker, MD
Issues and Controversies: CHF Frank W. Smart, MD
Issues and Controversies: Electrophysiology Gerald Naccarelli, MD
Lipids: Issues and Controversies Christie M. Ballantyne, MD
Answering Your Questions about Cardiac Surgery William E. Cohn, MD
Stem Cells Therapy for CV Disease Emerson C. Perin, MD, PhD

Program Directors

James J. Ferguson III, MD
Associate Director, Cardiology Research
Texas Heart Institute and St. Luke’s Episcopal Hospital
Houston, TX

R. David Fish, MD, FACC
Director, Interventional Cardiology Research and Education
Texas Heart Institute
Houston, TX

James T. Willerson, MD, FACC
President-Elect and Medical Director, Director of Cardiology Research, Co-Director of Cullen Cardiovascular Research Laboratories Texas Heart Institute
Houston, TX

Funding for this presentation has been provided by Bristol-Myers Squibb Company, Cordis Endovascular, Eli Lilly Corporation, and Medtronic, Inc.

Return to Explore Archived Symposia.

We subscribe to HONcode.
Verify here.

Please contact our Webmaster with questions or comments.
Terms of Use and Privacy Policy
© Copyright 1996-2009 Texas Heart Institute. All rights reserved.
Texas Heart Institute, Texas Heart, Texas Heart Institute Journal, THI, Heart Owner's, Leading With the Heart and Heart of Discovery are members of the
family of trademarks of the Texas Heart Institute.

USNews and World Report America's Best Hospitals - 2008